FOR IMMEDIATE RELEASE
OTTAWA – As the Senate prepares for its final vote on the Pharmacare Act today, marking a historic step toward a national drug plan, the Council of Canadians’ experts are available to comment on what lies ahead once the bill receives royal assent.
Our spokespeople are available to discuss:
- How to safeguard the “Committee of Experts” overseeing the national pharmacare program from corporate interference
- The urgency of delivering medications to Canadians swiftly to protect the program from a potential election victory by Pierre Poilievre, who has vowed to dismantle it if elected
- What to expect from provincial ministers and where resistance may arise
- How pharmacare will offer life-changing relief for those who live with diabetes or rely on contraception
- Debunking lies and misconceptions about pharmacare being spread by pharmaceutical and insurance company lobbyists, echoed by Pierre Poilievre
Spokespeople include:
- Nikolas Barry-Shaw, Pharmacare campaigner and researcher, who recently testified on pharmacare before the Senate SOCI Standing Committee
- Donya Ziaee, Director of Communications
More resources from us:
- Briefing note on Bill C-64 (Pharmacare Act) for the Senate SOCI Standing Committee
- Video of our testimony before the Senate SOCI Standing Committee
- Briefing note on Bill C-64 (Pharmacare Act) for the Parliamentary Standing Committee on Health
- “A Prescription for Profit”: our recent exposé on the institutions and experts attacking pharmacare on behalf of the pharmaceutical and insurance industries – several of which have testified before or submitted briefs on Bill C-64
For interviews, please contact:
media@canadians.org, 613-404-2004
